Zack Kubow | IR-Real Chemistry |
Leiv Lea | CFO |
Richard Miller | CEO |
James Rosenbaum | SVP-Research |
Aydin Huseynov | Ladenburg Thalmann |
Rosemary Li | Cantor Fitzgerald |
Jerry Gong | Mizuho |
Roger Song | Jefferies |
Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Corvus Pharmaceuticals First Quarter 2023 Business Update and Financial Results Conference Call. [Operator Instructions]
It is now my pleasure to turn the call over to Zack Kubow of Real Chemistry.
Thank you, operator, and good afternoon, everyone.